Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-99
SponsorCND Life Sciences

About this trial

The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease. The main question it aims to answer is:

Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkinson's disease?

Currently, Parkinson's disease is diagnosed by observing symptoms like tremors and movement problems, but by then the disease has already progressed significantly. Earlier detection could help doctors start treatment sooner.

Eligibility criteria

Qualifiers

Adults 40 to 99 years of age

Patients with a confirmed clinical diagnosis of Parkinson's disease by UKPDS Brain Bank Criteria

Patients who have agreed to undergo a routine colonoscopy as part of their surveillance for colon cancer or exclusion of other gastrointestinal diseases

Disqualifiers

Use of anticoagulants (Plavix 75 mg or aspirin up to 325 mg alone is allowed)

History of colon cancer

Recent gastrointestinal illness or surgical procedures

Pregnant or planning to become pregnant before the scheduled colonoscopy

Trial design

Treatments tested in this trial

  • No Intervention: Observational Cohort

Treatment groups

No treatment groups listed

Sponsors and collaborators

CND Life Sciences

Lead sponsor

Oregon Health and Science University

Collaborator